1. Home
  2. WFG vs IRTC Comparison

WFG vs IRTC Comparison

Compare WFG & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Fraser Timber Co. Ltd.

WFG

West Fraser Timber Co. Ltd.

HOLD

Current Price

$65.10

Market Cap

5.2B

Sector

N/A

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$124.05

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFG
IRTC
Founded
1955
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.8B
IPO Year
2007
2016

Fundamental Metrics

Financial Performance
Metric
WFG
IRTC
Price
$65.10
$124.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$89.50
$209.69
AVG Volume (30 Days)
215.6K
676.3K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
$5.36
$19.58
Revenue Next Year
$10.63
$15.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.24
52 Week Low
$57.34
$92.52
52 Week High
$79.33
$210.01

Technical Indicators

Market Signals
Indicator
WFG
IRTC
Relative Strength Index (RSI) 39.31 31.25
Support Level $58.30 N/A
Resistance Level $76.53 $167.19
Average True Range (ATR) 2.13 7.93
MACD -0.59 -1.36
Stochastic Oscillator 25.05 9.80

Price Performance

Historical Comparison
WFG
IRTC

About WFG West Fraser Timber Co. Ltd.

West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is one of the largest oriented strand board producers in the world.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: